Physician profile
Jeffrey Show Tran
NPI 1205377413
$79,311.15
in general payments reported to CMS, 2019-2025
10 companies · $78K in 2025
The $78K reported for 2025 was more than what 98% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,780 · 2025: $78K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $73K · Food and Beverage: $5,141 · Travel and Lodging: $778 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $73,392.00 |
| Food and Beverage | $5,140.59 |
| Travel and Lodging | $777.56 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $30,548.03 | 2024-2025 | Mitraclip, Dragonfly Opstar, Diamondback Coronary |
| Medtronic, INC. | $30,356.76 | 2024-2025 | Corevalve Evolut R, Onyx Frontier, Symplicity G3 |
| Boston Scientific Corporation | $15,590.34 | 2024-2025 | General - Structural Heart, Avvigo Guidance System, Watchman Access System |
| Edwards Lifesciences Corporation | $1,452.31 | 2024-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve, Pascal |
| Philips North America LLC | $653.35 | 2024-2025 | (Bq9) Coronary Ivus, Eagle Eye, (Br0) Coronary Atherectomy |
| Abiomed | $241.44 | 2024 | Impella |
| Shockwave Medical, INC | $186.70 | 2025 | |
| Penumbra, INC. | $150.00 | 2025 | Indigo System |
| Teleflex LLC | $112.62 | 2025 | Turnpike |
| Asahi Intecc USA, INC. | $19.60 | 2024 | Peripheral Vascular |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Tran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.